Product correctly added to cart.

discount label
SPL-410
View 3D

Biosynth logo

SPL-410

CAS: 2351886-00-3

Ref. 3D-BUD88600

1mg
517.00 €
2mg
801.00 €
5mg
1,160.00 €
10mg
1,855.00 €
25mg
3,826.00 €
Estimated delivery in United States, on Friday 27 Dec 2024

Product Information

Name:
SPL-410
Description:

SPL-410 is a Chinese anticancer drug that acts as a kinase inhibitor. It has been shown to induce apoptosis in cancer cells, making it an effective treatment option for various types of tumors. SPL-410 is an analog of Oseltamivir and Semaglutide, which are known inhibitors of human kinases. This drug has been found to be effective against a variety of cancers, including lung, breast, and colon cancer. It works by inhibiting the activity of tumor-associated kinases that are important for the growth and survival of cancer cells. SPL-410 is excreted in urine after metabolism by enzymes in the liver and kidneys. Its potent anticancer properties make it a promising candidate for the treatment of various types of cancer.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
500.58 g/mol
Formula:
C24H31F3N2O4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-BUD88600 SPL-410

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".